- Home
- » Tags
- » Pyrazinamide
Top View
- RIFATER (Rifampin, Isoniazid and Pyrazinamide USP) Tablets
- TB Eliminationtreatment of Multidrug-Resistant Tuberculosis
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- The Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in Singapore: Are Patients from South-East Asia Eligible?
- Towards Improved Treatment Outcomes for Tuberculosis Meningitis - Rethinking the Regimen
- Reactive Dirty Fragments: Implications for Tuberculosis Drug Discovery
- Tuberculosis Treatment Guidelines
- RIFATER® Rx Only (Rifampin, Isoniazid and Pyrazinamide USP)
- Methionine Antagonizes Para-Aminosalicylic Acid Activity Via Affecting 2 Folate Precursor Biosynthesis Pathway in Mycobacterium Tuberculosis
- Part 4 October 2017 Hydrochloride 150Mg/75Mg/400Mg/275Mg Film-Coated Section 7 Updated: April 2020 Tablets, (Micro Labs Limited), TB 223
- Antiinfectives Targeting Enzymes and the Proton Motive Force
- Chapter 6 Treatment of Tuberculosis Disease
- PYRAZINAMIDE TABLETS USP, 500 Mg Rx Only
- TB Elimination
- Section V. Treatment of Drug-Resistant Tuberculosis
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- AIDS-01: Pyrazinamide
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- Antibiotic Exposure Prior to Hospital Admission for Acute Liver Injury
- New Zealand Data Sheet
- Tips for Administering TB Medication to Children and Adults Who Are Unable to Swallow Pills
- Bedaquiline 100Mg Tablet
- An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy (2006)
- Current Overview of Anti-Tuberculosis Drugs: Metabolism and Toxicities
- Drug Utilization Patterns Among Elderly Hospitalized Patients on Poly
- (Pyrazin-2-Yl)Benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and in Silico Studies
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Pyrazinamide (PZA)
- Opposing Effects of Target Overexpression Reveal Drug Mechanisms
- Para-Aminosalicylate Sodium Delayed-Release Granules 60% W/W WHOPAR Part 4 September 2011 (Macleods Pharmaceuticals Ltd), TB156 Sections 2 & 6 Updated: February 2019
- FAQ Bedaquiline Implementation
- RIFATER® (Rifampin, Isoniazid and Pyrazinamide USP) Tablets
- Contribution of Pretomanid to Novel Regimens Containing Bedaquiline With
- Pyrazinamide (Pza) DRUG CLASS: SYNTHETIC DERIVATIVE of NICOTINAMIDE
- PYRAZINAMIDE TABLETS USP, 500 Mg Rx Only
- Part 4 June 2014 ( Antibiotice S
- Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
- Bedaquiline) Tablets Prolongation
- Bioassay of Pyrazinamide for Possible Carcinogenicity